Dihydroartemisinin-Piperaquine versus Artesunate-Amodiaquine: Superior Efficacy and Posttreatment Prophylaxis against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax Malaria

This publication has 38 references indexed in Scilit:

• Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, Indonesia
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 2007
• Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison
  The Lancet, 2007
• An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos)
  Tropical Medicine & International Health, 2006
• Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison
  The Lancet, 2006
• Hemiparesis and cerebellar dysfunction complicating mixed malarial infection with falciparum and vivax malaria
  Indian Journal of Medical Sciences, 2006
• Misattribution of Central Nervous System Dysfunction to Artesunate
  Clinical Infectious Diseases, 2005
• Toxic brainstem encephalopathy after artemisinin treatment for breast cancer
  Annals of Neurology, 2005
• The global distribution and population at risk of malaria: past, present, and future
  The Lancet Infectious Diseases, 2004
• Therapeutic Efficacies of Artesunate-Sulfadoxine-Pyrimethamine and Chloroquine-Sulfadoxine-Pyrimethamine in Vivax Malaria Pilot Studies: Relationship to Plasmodium vivax dhfr Mutations
  Antimicrobial Agents and Chemotherapy, 2002
• PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
  The Lancet, 1989